StockData
NEXGEL, Inc. logo

NEXGEL, Inc. (NXGLW) stock

NXGLWNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as NXGL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026Score 6/3072% below fair value
$0.01+0.00 (0.00%)

Close on Oct 30, 2026Market cap $34.21MP/E –Yield –

Nexgel shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Nexgel's shares outstanding was 9M at Jun 30, 2026. For fiscal 2025 it was 8M, up 20.6% from the year before. The highest annual figure on record is 8M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20258M+20.6%
FY2024Dec 31, 20247M+14.8%
FY2023Dec 31, 20236M+1.7%
FY2022Dec 31, 20226M+87.1%
FY2021Dec 31, 20213M+32.2%
FY2020Dec 31, 20202M+481.4%
FY2019Dec 31, 20190M+171.1%
FY2018Dec 31, 20180M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20269M+17.8%
Q1 FY2026Mar 31, 20268M+7.3%
Q4 FY2025Dec 31, 20258M+12.8%
Q3 FY2025Sep 30, 20258M+21.3%
Q2 FY2025Jun 30, 20258M+22.4%
Q1 FY2025Mar 31, 20258M+27.8%
Q4 FY2024Dec 31, 20247M+26.2%
Q3 FY2024Sep 30, 20247M+15.0%
Q2 FY2024Jun 30, 20246M+10.5%
Q1 FY2024Mar 31, 20246M+7.1%
Q4 FY2023Dec 31, 20236M+2.5%
Q3 FY2023Sep 30, 20236M+2.5%
Q2 FY2023Jun 30, 20236M-99.9%
Q1 FY2023Mar 31, 20236M-99.9%
Q4 FY2022Dec 31, 20226M+80.5%
Q3 FY2022Sep 30, 20226M-99.8%
Q2 FY2022Jun 30, 20225.57B+189442.3%
Q1 FY2022Mar 31, 20225.57B+193851.2%
Q4 FY2021Dec 31, 20213M+23.6%
Q3 FY2021Sep 30, 20212.98B+119843.8%
Q2 FY2021Jun 30, 20213M+34.8%
Q1 FY2021Mar 31, 20213M+55.8%
Q4 FY2020Dec 31, 20203M+1423.4%
Q3 FY2020Sep 30, 20202M+1637.0%
Q2 FY2020Jun 30, 20202M+1425.2%
Q1 FY2020Mar 31, 20202M+1189.1%
Q3 FY2019Sep 30, 20190M+14.9%
Q2 FY2019Jun 30, 20190M–
Q1 FY2019Mar 31, 20190M–
Q4 FY2018Dec 31, 20180M–
Q3 FY2018Sep 30, 20180M–
Q2 FY2018Jun 30, 20180M–

More Nexgel figures